Ron Sahatjian, Medi-Vantage Team Member, accepted as a Fellow of AIMBE

We are proud and pleased that Ron Sahatjian, Medi-Vantage team member was nominated and accepted as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).

Ron had a celebrated career as Vice President of Corporate R&D at Boston Scientific and is renowned as an inventor and innovator in global product development, with greater than 100 US patents issued. He has significant experience in medtech M&A, due diligence and board of directors advisory services. He has raised capital, started and sold two companies, one in China. His patent portfolio includes innovation in Cardiovascular, Drug Delivery, GI Endoscopy, Orthopedics, Peripheral Vascular and Urology.

The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization headquartered in Washington, D.C., representing the most accomplished individuals in the fields of medical and biological engineering. AIMBE represents the most accomplished the top 2% of medical and biological engineers from academic institutions, private industry, and professional engineering societies. AIMBE was founded in 1991 and its current vision is to provide leadership and advocacy in medical and biological engineering for the benefit of society.

AIMBE is an advocate for public policy issues related to improving lives through medical and biological engineering. The College of Fellows is comprised of experts like Ron in areas such as clinical practice, industrial practice, and education.  Fellows and constituents of AIMBE cultivate ideas and address current issues by attending national events intended to advance the mission of AIMBE.  AIMBE consistently provides a reliable, authoritative voice during dialogue with lawmakers and stakeholders in product development.  By fostering relationships with related organizations and individuals, AIMBE lays a foundation for policy-making effective in improving the lives of citizens and patients.


AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society.  It is an organization of leaders in medical and biological engineering, consisting of academic, industrial, professional society councils and elected fellows. As such, AIMBE will:

  • Communicate objectively with, and respond to, U.S. and state government agencies, Congress, industry, academia, and professional societies by advocating and providing service to the public via medical and biological engineering
  • Contribute to public policy-making to advance medical and biological engineering and benefit the general public
  • Work to ensure appropriate private and public investment to advance medical and biological engineering translational research and innovation
  • Inspire, educate, and involve young people who will be the future leaders of medical and biological engineering
  • Promote intersociety and multi-disciplinary cooperation within the medical and biological engineering community
  • Recognize and honor individual and group achievements and contributions to the field of medical and biological engineering


  • The College of Fellows – More than 1,500 individuals who are the outstanding biomedical and biological engineers in academia, industry, and government. These leaders in the field have distinguished themselves through their contributions in research, industrial practice and/or education. Potential Fellows are nominated by current AIMBE Fellows. Nominees are then reviewed by a subcommittee catered to their professional expertise or accomplishments. If a nominee gains approval from a subcommittee, they are then voted upon by the entire fellowship. Candidates who receive approval from the majority of the College of Fellows are inducted during the AIMBE Annual Event.  Members retain lifelong membership.